These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 25387323)

  • 1. Massive asymptomatic creatine kinase elevation in youth during antipsychotic drug treatment: case reports and critical review of the literature.
    Masi G; Milone A; Viglione V; Mancini A; Pisano S
    J Child Adolesc Psychopharmacol; 2014 Dec; 24(10):536-42. PubMed ID: 25387323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antipsychotics and rhabdomyolysis. Differential diagnosis and clinical significance of elevated serum creatine kinase levels in psychiatric practice].
    Vörös V; Osváth P; Fekete S; Tényi T
    Psychiatr Hung; 2009; 24(3):175-84. PubMed ID: 19794225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. All elevated creatine kinase is not neuroleptic malignant syndrome.
    Maniam T; Rahman MA
    Med J Malaysia; 1994 Sep; 49(3):252-4. PubMed ID: 7845275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuroleptic malignant syndrome : Rare cause of fever of unknown origin].
    Chackupurakal R; Wild U; Kamm M; Wappler F; Reske D; Sakka SG
    Anaesthesist; 2015 Jul; 64(7):527-31. PubMed ID: 26122200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marked elevation of serum creatine kinase associated with olanzapine therapy.
    Marcus EL; Vass A; Zislin J
    Ann Pharmacother; 1999 Jun; 33(6):697-700. PubMed ID: 10410183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconsidering Rigidity in the Diagnosis of Neuroleptic Malignant Syndrome: A Case Report.
    El Khoury R; Kassab A; Dagher R; Javelot H; El Chammay R; Richa S
    J Psychiatr Pract; 2020 Jul; 26(4):320-323. PubMed ID: 32692129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhabdomyolysis reported for children and adolescents treated with antipsychotic medicines: a case series analysis.
    Star K; Iessa N; Almandil NB; Wilton L; Curran S; Edwards IR; Wong IC
    J Child Adolesc Psychopharmacol; 2012 Dec; 22(6):440-51. PubMed ID: 23234587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rhabdomyolysis in neuroleptic therapy: an abortive malignant neuroleptic syndrome?].
    Peschel O; Kurtz G; Müller-Felber W; Modell S
    Nervenarzt; 1994 Oct; 65(10):718-21. PubMed ID: 7808573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuroleptic malignant syndrome after 30 years treatment with clozapine: a rarely seen differential diagnosis on intensive care units].
    Franzen D; Burkhard J; Corti N; Schüpbach D; Fontanel D; Stäubli M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2006 Feb; 41(2):125-7. PubMed ID: 16493563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amisulpride and neuroleptic malignant syndrome.
    Tu MC; Hsiao CC
    Chang Gung Med J; 2011; 34(5):536-40. PubMed ID: 22035899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Olanzapine induced rhabdomyolysis and serum creatine kinase increase].
    Ribeyron S; Guy C; Koenig M; Cathébras P
    Rev Med Interne; 2009 Jun; 30(6):477-85. PubMed ID: 19307047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Massive creatine kinase elevations with quetiapine: report of two cases.
    Klein JP; Fiedler U; Appel H; Quante A; Jockers-Scherübl MC
    Pharmacopsychiatry; 2006 Jan; 39(1):39-40. PubMed ID: 16453254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinguishing neuroleptic malignant syndrome (NMS) from NMS-like acute medical illnesses: a study of 34 cases.
    Sewell DD; Jeste DV
    J Neuropsychiatry Clin Neurosci; 1992; 4(3):265-9. PubMed ID: 1354002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ziprasidone- and lithium-induced neuroleptic malignant syndrome.
    Borovicka MC; Bond LC; Gaughan KM
    Ann Pharmacother; 2006 Jan; 40(1):139-42. PubMed ID: 16352776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of creatine kinase in the diagnosis of neuroleptic malignant syndrome.
    O'Dwyer AM; Sheppard NP
    Psychol Med; 1993 May; 23(2):323-6. PubMed ID: 8101383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical neuroleptic malignant syndrome in patients treated with aripiprazole and clozapine: a case-series study and short review.
    Tseng PT; Chang YC; Chang CH; Wang HY; Cheng YS; Wu CK; Chen YW; Chung W
    Int J Psychiatry Med; 2015; 49(1):35-43. PubMed ID: 25838319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool.
    Sokoro AA; Zivot J; Ariano RE
    Ann Pharmacother; 2011 Sep; 45(9):e50. PubMed ID: 21878660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The myth of elevated serum creatine phosphokinase level and neuroleptic malignant syndrome.
    Adityanjee
    Br J Psychiatry; 1991 May; 158():706-7. PubMed ID: 1677602
    [No Abstract]   [Full Text] [Related]  

  • 19. Antipsychotic-Induced Neuroleptic Malignant Syndrome After Cardiac Surgery.
    Moll V; Ward CT; Zivot JB
    A A Case Rep; 2016 Jul; 7(1):5-8. PubMed ID: 27191714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic malignant syndrome secondary to olanzapine, a presentation with severe acute kidney injury requiring hemodialysis: a case report.
    Chang CK; Payus AO; Noh MM; Lansing MG; Sumpat D; Lu SJA; Yew BT
    J Med Case Rep; 2022 Oct; 16(1):366. PubMed ID: 36203196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.